Maria Expósito Lorido has taken on the role of Associate Director, Strategic Business Solutions at Thermo Fisher Scientific. This move reflects the company’s focus on data-driven healthcare. It also highlights the growing importance of Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR).
In this role, she leads high-impact, technology-driven initiatives. She focuses on delivering clear and measurable business outcomes. She works closely with teams across the organisation to improve processes and performance.
She also converts complex healthcare challenges into simple, structured strategies. At the same time, she uses data insights to guide decisions. In addition, she ensures that key initiatives move from planning to execution without delays.
Her role demands strong ownership and consistent delivery. It also requires a sharp focus on scalable impact across global markets.
A Career Built at the Intersection of Pharma, MedTech and AI
Expósito Lorido brings experience across clinical leadership, venture capital, and healthcare innovation. Her career shows a clear focus on combining science, strategy, and technology.
She worked as a Venture Partner at VU Venture Partners. There, she led investment sourcing and due diligence. She also helped shape portfolio strategy in healthcare and other high-growth sectors.
Earlier, she served as Global Clinical Project Leader at Parexel. In that role, she managed biotech programs, including those for rare and underserved diseases. She focused on both clinical progress and operational efficiency.
She has also held growth and advisory roles. In these roles, she supported global expansion and regulatory alignment. She helped organisations improve operations and scale effectively.
Across all positions, she connects clinical outcomes with business growth. She does this through ethical AI and real-world data.
Strengthening Strategic Business Solutions at Thermo Fisher
At Thermo Fisher Scientific, she will strengthen strategic planning and execution. She will improve how teams track performance and outcomes.
She will also align commercial and operational goals across business units. This alignment will support faster and more effective decision-making.
In addition, she will help advance AI-led healthcare innovation. Her work in RWE and HEOR supports evidence-based decisions. These decisions matter for payers, providers, and pharmaceutical companies worldwide.
Thought Leadership and Global Healthcare Impact
Expósito Lorido also contributes beyond her corporate role. She founded a global healthcare innovation network. This platform supports leaders working in complex markets.
She helps organisations prepare for investment and growth. She also advises on market entry and regulatory strategy. In many cases, she supports companies expanding into new regions.
Her work focuses on scaling healthcare solutions across borders. She combines regulatory knowledge with strong business insight. This approach helps turn ideas into practical outcomes.
Strategic Significance of the Appointment
The healthcare sector continues to evolve at a fast pace. Companies now focus more on personalised and data-driven care. At the same time, AI plays a larger role in both clinical and operational systems.
Global collaboration has also increased. Cross-border innovation now shapes healthcare growth.
In this context, Expósito Lorido’s appointment strengthens Thermo Fisher Scientific’s strategic direction. Her role supports the integration of technology, strategy, and clinical expertise. This integration will drive the next phase of healthcare innovation.
